{"organizations": [], "uuid": "ab9616795d744f1e2f72fda95a64d2e3693026e1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-engaged-capital-reports-52-pct-sta/brief-engaged-capital-reports-5-2-pct-stake-in-aratana-therapeutics-inc-as-of-april-4-2018-sec-filing-idUSFWN1RI0FY", "country": "US", "domain_rank": 408, "title": "BRIEF-Engaged Capital Reports 5.2 Pct Stake In Aratana Therapeutics Inc, As Of April 4, 2018 SEC Filing", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-05T16:12:00.000+03:00", "replies_count": 0, "uuid": "ab9616795d744f1e2f72fda95a64d2e3693026e1"}, "author": "", "url": "https://www.reuters.com/article/brief-engaged-capital-reports-52-pct-sta/brief-engaged-capital-reports-5-2-pct-stake-in-aratana-therapeutics-inc-as-of-april-4-2018-sec-filing-idUSFWN1RI0FY", "ord_in_thread": 0, "title": "BRIEF-Engaged Capital Reports 5.2 Pct Stake In Aratana Therapeutics Inc, As Of April 4, 2018 SEC Filing", "locations": [], "entities": {"persons": [{"name": "lowell robinson", "sentiment": "none"}, {"name": "craig barbarosh", "sentiment": "none"}], "locations": [{"name": "arata", "sentiment": "none"}], "organizations": [{"name": "sec", "sentiment": "negative"}, {"name": "aratana therapeutics inc", "sentiment": "negative"}, {"name": "therapeutics inc", "sentiment": "none"}, {"name": "sec filing reuters", "sentiment": "none"}, {"name": "eric ende", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 5, 2018 / 1:13 PM / Updated 8 minutes ago BRIEF-Engaged Capital Reports 5.2 Pct Stake In Aratana Therapeutics Inc, As Of April 4, 2018 SEC Filing Reuters Staff \nApril 5 (Reuters) - Aratana Therapeutics Inc: * SEC FILING \n* ENGAGED CAPITAL LLC SAYS PURCHASED ARATANA THERAPEUTICS’ SHARES BASED ON BELIEF THAT THE SHARES, WHEN PURCHASED, WERE UNDERVALUED \n* ENGAGED CAPITAL LLC SAYS HAS ENGAGED, TO CONTINUE TO ENGAGE, IN COMMUNICATIONS WITH ARATANA THERAPEUTICS BOARD FOR MEANS TO CREATE STOCKHOLDER VALUE \n* ON MARCH 23, DELIVERED LETTER TO ARATANA THERAPEUTICS NOMINATING CRAIG BARBAROSH, ERIC ENDE, LOWELL ROBINSON FOR ELECTION TO BOARD ‍​ Source text: ( bit.ly/2HaDmA3 ) Further company coverage:", "external_links": [], "published": "2018-04-05T16:12:00.000+03:00", "crawled": "2018-04-05T16:22:56.001+03:00", "highlightTitle": ""}